63rd American Society of Hematology (ASH) Annual Meeting and Exposition – Non-Audio Presentation

by Asa Elmore | Jan 11, 2022 | Events, News, Presentations

63rd American Society of Hematology (ASH) Annual Meeting and Exposition – Non-Audio Presentation...

40th Annual J.P. Morgan Heathcare Conference – Presentation

by Asa Elmore | Jan 10, 2022 | Events, News, Presentations

40th Annual J.P. Morgan Heathcare Conference – Presentation Webcast, Jan 13, 2022 at 11:15AM EST...

Sutro Biopharma to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference

by Asa Elmore | Jan 6, 2022 | Events, News, Presentations, Press Releases

Sutro Biopharma to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference SOUTH SAN FRANCISCO, Calif., Jan. 6, 2022– Sutro Biopharma, Inc. (“Sutro” or the “Company”) (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company...

Virtual KOL Event: Discussion of STRO-002 Interim Dose Expansion Cohort Data – Presentation

by Asa Elmore | Jan 5, 2022 | Events, News, Presentations

Virtual KOL Event: Discussion of STRO-002 Interim Dose Expansion Cohort Data – Presentation Webcast, Jan 5, 2022 at 5:00pm EST...

Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer

by Asa Elmore | Jan 5, 2022 | Events, News, Presentations, Press Releases

Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer – 33% Objective Response Rate (ORR) was observed in 33 RECIST evaluable patients across all FolRα expression levels and both...